PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
September 12, 2025CureusOpen Access

Cardiovascular Risk in Autoimmune Diseases: Mechanisms, Management, and Emerging Evidence

View Full Paper
Ask AI
Bookmark
Share

Authors

MBMaheen Bhangwar BalochCAChris AlphonseNBNehal Baldev

Discussion

Loading...

Member takes

Overview

This review highlights cardiovascular outcomes in autoimmune disorders, suggesting biologic therapies may improve risk management.

Key Points

  • Cardiovascular disease is a leading cause of morbidity in autoimmune patients, requiring effective management strategies.
  • Emerging evidence shows that biologic therapies can improve cardiovascular outcomes by addressing systemic inflammation.
  • Advanced vascular imaging allows for early detection of atherosclerosis, enhancing patient management.
  • Lifestyle interventions, alongside pharmacologic measures like statins, are crucial for mitigating cardiovascular risk.

Cite This Study

Baloch et al. (2025) studied this question.

synapsesocial.com/papers/68d44c4631b076d99fa55ab4https://doi.org/10.7759/cureus.91897
View Full Paper
Ask AI
Bookmark
Share